A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Vaccine ...
Moderna conducted a study to test a combination COVID-19 and flu shot. Researchers tested the shot on 8,000 adults. The pharmaceutical and biotechnology company is targeting 2026 for approval of the ...
Moderna said its combination vaccine targeting Covid and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. The biotech company is the first to release ...
(Gray News) - A combination shot for flu and COVID-19 using messenger RNA-generated antibodies in a study, but U.S. government regulators want to see data on whether the new vaccine protects people ...
Stream NBC 5 for free, 24/7, wherever you are. Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results